Summary Information:
OpGen Inc. Common Stock
NASDAQ:OPGN


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


OpGen Inc. Common Stock
Exchange: NASDAQ
Symbol: OPGN
SEC CIK: 0001293818
Phone: 240-813-1260
9717 KEY WEST AVENUE
SUITE 100
ROCKVILLE MD 20850
CEO: Oliver Schacht
Price when page updated: 0.4169 Date: 2023-12-01
Company Website:
www.opgen.com

_Description: OpGen, Inc. (Gaithersburg, MD, USA) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with subsidiaries, Curetis GmbH and Ares Genetics GmbH, OpGen is developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. OpGen's product portfolio includes Unyvero, Acuitas®AMR Gene Panel and Acuitas® Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction.

IPO YEAR:
2015
Sector:
Health Care
Industry:
Medical Specialities
ADRTSO:

MarketCap:
4174638.00
Beta:
1.051673001684729
52 Week High:
4.37
52 Week Low:
0.955
52 Week Change:
-0.34705882352941164
Short Interest:

Short Date:

Shares Outstanding:
38950250
Dividend Rate:
0
Dividend Yield:
1.33%
ExDividend Date:

Latest EPS:

Latest EPS Date:
26 Oct 2022
Float:
0
return on Equity:
-11.00%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$120.130M
ttmEPS:
0
Revenue:
$284.916M
Gross Profit:

Cash:

Debt:

Institution Percent:
58.10%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
15.70%
Return on Assets:
-3.50%
Return on Capital:

Profit Margin:
-2.60%
Price to Sales:
0.23
Price To Book:
0.98
Short Ratio:
4.15
PE Ratio:
0
Employees:
102
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__OpGen Inc. Common Stock [ OPGN ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01